Women with a family history of breast cancer could be offered preventative medication on the NHS under new plans outlined by the health regulator.
Officials are examining whether women who are at "high risk" of developing the disease should be offered hormone therapy to prevent breast cancer.
The National Institute of Health and Clinical Excellence (Nice) has launched a draft consultation to see whether drugs tamoxifen or raloxifene should be offered to high-risk post-menopausal women in England and Wales.
More top news
The move was welcome by the Royal British Legion, which said the time should be one of reconciliation.
At some point, the elastic that ties Brexiter ministers to government will snap and one or more of them will quit. But probably not today.
Police in London responded to an incident of a different kind on Sunday night when they delivered a baby in the street.